Average Co-Inventor Count = 6.20
ph-index = 13
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Frosst Canada, Inc. (21 from 212 patents)
2. Merck Frosst Canada & Co. (9 from 76 patents)
3. Axys Pharmaceuticals, Inc. (4 from 40 patents)
4. Actelion Pharmaceuticals Ltd (2 from 217 patents)
5. Debiopharm International, S.a. (2 from 20 patents)
6. Merck + Co., Inc. (1 from 4,770 patents)
7. Merck Sharp + Dohme Corp. (1 from 2,405 patents)
8. Merck Canada Inc. (1 from 40 patents)
9. Merck Frosst Canada Inc./merck Frosst Canada & Co. (1 from 1 patent)
37 patents:
1. 10035813 - Prodrug derivatives of (E)-N-methyl-N-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide
2. 8901105 - Prodrug derivatives of (E)-N-methyl-N-((3-M ethylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide
3. 8772336 - Cathepsin cysteine protease inhibitors
4. 8318748 - Cathepsin cysteine protease inhibitors
5. 7973037 - Cathepsin cysteine protease inhibitors
6. 7968720 - Secondary amines as renin inhibitors
7. 7799805 - Piperidine carboxylic acid amide derivatives
8. 7629467 - Diphenyl substituted cycloalkanes, compositions containing such compounds and methods of use
9. 7375134 - Cathepsin cysteine protease inhibitors
10. 6498151 - Aryldifluoromethylphosphonic acids with sulfur-containing substituents as PTP-1B inhibitors
11. 6486141 - Phosphonic acid biaryl derivatives as inhibitors of protein tyrosine phosphatase 1B (PTP-1B)
12. 6486142 - Phosphonic acid derivatives as inhibitors of protein tyrosine phosphatase 1B (PTP-1B)
13. 6486194 - Use of inhibitors of cyclooxygenase in the treatment of neurodegenerative diseases
14. 6465509 - Pyrones as inhibitors of cyclooxygenase-2
15. 6329421 - Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2